Qualcomm Plans to Add ChatGPT to Mobile Devices

Date:

Qualcomm is working on a new generation of processors that will allow AI models like GPT-4 and DALL-E2 to run on smartphones. Presently, users can access these models through the web or mobile apps, but the cost of running them is high. The majority of this cost is used to run servers, with chatGPT costing OpenAI approximately $700,000 per day. However, Qualcomm’s new generation processors will allow generative AI developers and providers to utilise the computing power of edge devices, which can result in cost reduction. The development of AI chips and algorithms is attracting companies like Apple, Google, and Microsoft, who recognise the importance of on-device AI models. Although Apple is not yet developing GPT models like Large Language Models (LLM), it is investing heavily in AI chips and algorithms which can run on iPhones, iPads, and Macs. In the future, the ability to run AI models on devices could be an approach for other companies in the artificial intelligence industry.

See also  Microsoft CEO Nadella Hires Ousted OpenAI CEO Altman to Lead Advanced AI Research, Sparks Speculation, US

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.